| -
Bordini BJ, Walsh RD, Basel D, Deshmukh T. Attaining Diagnostic Excellence: How the Structure and Function of a Rare Disease Service Contribute to Ending the Diagnostic Odyssey. Med Clin North Am.
2024;108(1):1-14. doi:10.1016/j.mcna.2023.06.013
- Bulaklak K, Gersbach CA. The once and future gene therapy. Nat Commun. 2020;11(1):5820. Published 2020 Nov 16. doi:10.1038/s41467-020-19505-2
-
Fraiman YS, Wojcik MH. The influence of social determinants of health on the genetic diagnostic odyssey: who remains undiagnosed, why, and to what effect?. Pediatr Res. 2021;89(2):295-300.
doi:10.1038/s41390-020-01151-5
- Groft SC, Posada M, Taruscio D. Progress, challenges and global approaches to rare diseases. Acta Paediatr. 2021;110(10):2711-2716. doi:10.1111/apa.15974
- Nussbaum, R.L., McInnes, R.R., & Willard, H.F. (2015). Thompson & Thompson Genetics in Medicine (8ª Edição). Elsevier Health Sciences.
-
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the
Association for Molecular Pathology. Genet Med. 2015;17(5):405-424. doi:10.1038/gim.2015.30
-
Tambuyzer E, Vandendriessche B, Austin CP, et al. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.Nat Rev Drug Discov. 2020;19(2):93-111.doi:10.1038/s41573-019-0049-9
- Turnpenny, P.D., Ellard, S., & Cleaver, R. (2020). Emery’s Elements of Medical Genetics (16ª Edição). Elsevier Health Sciences.
- https://www.ejprarediseases.org/what-is-ejprd/project-structure/
- MOOC “Diagnosing rare diseases: from the clinic to research and back”
- MOOC “Introduction to Translational Research for Rare Diseases”
|